Inhibikase Therapeutics, Inc.
IKTNasdaqCIK 1750149HealthcareFiscal year ends Dec 31
Reports and events: 122 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2020:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-426811 |
| 2026-09-0820:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385293 |
| 2026-08-2620:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-368296 |
| 2026-08-1120:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-344707 |
| 2026-08-1120:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344623 |
| 2026-07-2920:05 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-323651 |
| 2026-07-2312:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-313400 |
| 2026-07-1412:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-302580 |
| 2026-06-2910:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-286747 |
| 2026-05-1220:39 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219641 |
| 2026-05-1220:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219610 |
| 2026-04-3020:05 ET | DEF 14A | Proxy statementPeriod 2026-06-26 | 0001193125-26-197177 |
| 2026-04-0712:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-144582 |
| 2026-03-2620:32 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-126371 |
| 2026-03-2620:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126322 |
| 2025-12-1921:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-326916 |
| 2025-11-2121:28 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-291443 |
| 2025-11-2021:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-289768 |
| 2025-11-1421:37 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-283169 |
| 2025-11-1421:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-283075 |
| 2025-08-1421:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-180899 |
| 2025-08-1420:56 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-180889 |
| 2025-06-3020:29 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-152767 |
| 2025-05-1421:29 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071635 |
| 2025-05-1421:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-119939 |
| 2025-05-1220:05 ET | DEF 14A | Proxy statementPeriod 2025-06-27 | 0000950170-25-069152 |
| 2025-04-2520:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-058693 |
| 2025-04-1412:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-079656 |
| 2025-03-2720:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-046096 |
| 2025-03-2720:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-065511 |
| 2025-02-2413:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-032821 |
| 2025-02-1813:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-028188 |
| 2025-01-2921:05 ET | 8-K | 8.01 Other events | 0001193125-25-015648 |
| 2025-01-0611:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-001787 |
| 2024-12-0521:50 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-24-271609 |
| 2024-11-1821:05 ET | DEF 14A | Proxy statementPeriod 2025-01-03 | 0000950170-24-127941 |
| 2024-11-1413:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126766 |
| 2024-10-2201:13 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-240603 |
| 2024-10-1021:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-236039 |
| 2024-10-0912:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-234814 |
| 2024-08-1420:14 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-097022 |
| 2024-08-0601:21 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-194177 |
| 2024-06-2022:06 ET | DEF 14A | Proxy statementPeriod 2024-08-05 | 0000950170-24-075675 |
| 2024-06-1821:27 ET | S-1 | Registration statement | 0001193125-24-163529 |
| 2024-06-1020:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-158318 |
| 2024-05-2012:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-142317 |
| 2024-05-1521:04 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-060579 |
| 2024-05-0918:41 ET | S-1/A | Registration statement, amended | 0001193125-24-135161 |
| 2024-05-0900:44 ET | S-1/A | Registration statement, amended | 0001193125-24-134515 |
| 2024-04-3012:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-123758 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.